Hospices Civils de Lyon, Department of Hematology, Lyon-Sud Hospital, Pierre Bénite 69495, France Therapy-related acute myeloid leukaemia and acute myeloid leukaemia with myelodysplasia-related ...

Exploratory Analysis of Brigatinib Activity in Patients With Anaplastic Lymphoma Kinase-Positive Non–Small-Cell Lung Cancer and Brain Metastases in Two Clinical Trials This phase III, open-label study ...

Capital Power Corporation's (TSE:CPX) weak earnings were disregarded by the market. Despite the strength in the stock, we feel that investors should be cautious about some numbers in the earnings. AI ...

Five-year follow-up data from the phase 3 CLTR0310-301 clinical trial shows continued OS benefit with the novel agent CPX-351 in acute myeloid leukemia subgroups. Treatment with CPX-351 (Vyxeos) in ...

Donor Lymphocyte Infusions Modulate Relapse Risk in Mixed Chimeras and Induce Durable Salvage in Relapsed Patients After T-Cell–Depleted Allogeneic Transplantation for Hodgkin's Lymphoma Fig 1.

The Cpx-mediated envelope stress response is crucial for envelope maintenance in Gram-negative bacteria. Strikingly, researchers have reported very few natural stresses that induce the Cpx pathway.

CPX-351 (Vyxeos) has been granted a breakthrough therapy designation by the FDA as a treatment for patients with therapy-related acute myeloid leukemia (t-AML) or AML with myelodysplasia-related ...

Abu Dhabi, UAE – CPX, a leading provider of cutting-edge cyber and physical security solutions and services, today unveiled its strategic expansion plan to accelerate growth, broaden its global ...